N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial
Tan, W W, Hillman, D W, Salim, M, Northfelt, D W, Anderson, D M, Stella, P J, Niedringhaus, R, Bernath, A M, Gamini, S S, Palmieri, F, Perez, E AJournal:
Annals of Oncology
DOI:
10.1093/annonc/mdx811
Date:
January, 2018
File:
PDF, 41 KB
2018
File converter
More search results
More benefits 
